 |
| Shane McDevitt |
Imre Health has recruited Digitas Health's Shane McDevitt as director of its medical and scientific affairs unit.
As medical editor at Digitas Health, McDevitt specialized in oncology brands. He will lead a team responsible for new therapies across the pharmaceutical, biotech and biopharmaceutical categories, while integrating medical and scientific savvy into existing practices.
Imre, which handles clients such as AstraZeneca, GlaxoSmithKline, Pfizer, Bausch Health and EQRx, ranked No. 8 on O'Dwyer's 2020 rankings of independent healthcare firms with fees of $21M.
Jeff Smokler, President of Imre Health, said his goal is to build a new agency model, where medicine and science sit among—rather than adjacent to—the integrated suite of strategic and creative services the agency delivers.
The firm added Josh Simon as VP-social health marketing earlier this year. He joined from AstraZeneca.
Imre has offices in Baltimore, Philadelphia, New York and Los Angeles.
The future of DTC should foster understanding and trust, as well as improving clinical conversations.
Healing the Sick Care System: Why People Matter, a new book from FINN Partners chair global health and purpose Gil Bashe, says that the current healthcare system is not broken because it lacks innovation, talent or investment, but because it has lost sight of the people it exists to serve.
Jeff Smokler, former president at healthcare specialist imre, joins Washington-based Avoq to head its PA practice.
